GE HealthCare gets FDA clearance for Portrait Mobile patient monitor
Getty Images/Getty Images News
GE HealthCare (NASDAQ:GEHC) said it has received FDA clearance for its Portrait Mobile wearable patient monitoring device.
The wireless product, which is the size of a smart phone, provides real-time monitoring of patient vital signs while allowing them to be mobile during critical recovery periods, such as following surgery. The device is intended to help clinicians spot patient deterioration more quickly. 
More on GE HealthCare:


BofA starts GE HealthCare at neutral, sees margin upside priced in


GE HealthCare Technologies Inc. (GEHC) Q2 2023 Earnings Call Transcript


GE HealthCare Technologies Inc. 2023 Q2 - Results - Earnings Call Presentation


GE HealthCare Technologies beats Q2 top and bottom line estimates; raises full-year guidance


GE HealthCare: Good Growth Prospects At A Reasonable Valuation


GE HealthCare Technologies: Q2 2023 Earnings Solidify Bullish Case